...
首页> 外文期刊>Journal of Cancer Research and Therapeutics >Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone
【24h】

Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone

机译:睾丸癌的晚期复发:24年后复发,仅接受化疗

获取原文
           

摘要

Late relapse of testicular cancer, defined as >2 years interval between initial treatment and recurrence, is a rare disease with the incidence rate of 2.6%. Due to its chemoresistant features, treatment options of late relapses are controversial while surgical approach and cisplatin-based chemotherapies can be considered. We report here a patient with nonseminomatous germ cell tumor who experienced relapse 24 years after his first diagnosis. After detecting left supraclavicular lymphadenopathy and absence of any other malignant lesion in positron emission tomography-computerized tomography, patient was treated with three cycles of VeIP regimen (vinblastine/ifosfamide/cisplatin). Second complete response to this treatment was achieved with chemotherapy alone.
机译:睾丸癌的晚期复发定义为初始治疗和复发之间的间隔时间> 2年,是一种罕见疾病,发病率为2.6%。由于其化学抗药性,晚期复发的治疗选择引起争议,同时可以考虑手术方法和基于顺铂的化学疗法。我们在这里报告了一名非精原细胞生殖细胞肿瘤患者,他在首次诊断后24年就复发了。在正电子发射断层扫描计算机断层扫描中检测到左锁骨上淋巴结肿大且无其他恶性病变后,患者接受了三个周期的VeIP方案(长春碱/异环磷酰胺/顺铂)治疗。仅使用化学疗法即可达到对该治疗的第二次完全缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号